Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,208 | -9,325 | -32,451 | -25,544 | -17,209 |
| Depreciation Amortization | 923 | 457 | 1,566 | 1,092 | 871 |
| Accounts receivable | 258 | 859 | -670 | -168 | -623 |
| Other Working Capital | -2,136 | 56 | -4,086 | -2,263 | -3,074 |
| Other Operating Activity | 2,205 | 239 | 318 | -541 | 503 |
| Operating Cash Flow | $-15,958 | $-7,714 | $-35,323 | $-27,424 | $-19,532 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -886 | -25 | -560 | -458 | -433 |
| Investing Cash Flow | $-886 | $-25 | $-560 | $-458 | $-433 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 9,444 | 9,444 | N/A |
| Debt Repayment | -140 | -71 | -4,529 | -4,460 | -2,230 |
| Common Stock Issued | 5,897 | 5,343 | 16,135 | 11,887 | 2,756 |
| Other Financing Activity | -64 | -56 | -913 | -854 | 0 |
| Financing Cash Flow | $5,693 | $5,216 | $20,137 | $16,017 | $526 |
| Beginning Cash Position | 36,922 | 36,922 | 52,668 | 52,668 | 52,668 |
| End Cash Position | 25,771 | 34,399 | 36,922 | 40,803 | 33,229 |
| Net Cash Flow | $-11,151 | $-2,523 | $-15,746 | $-11,865 | $-19,439 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,958 | -7,714 | -35,323 | -27,424 | -19,532 |
| Capital Expenditure | -886 | -25 | -560 | -458 | -433 |
| Free Cash Flow | -16,844 | -7,739 | -35,883 | -27,882 | -19,965 |